HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

(+-)-Adrenaline

HCID 838
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
329-65-7
Standard SMILES
CNCC(O)c1ccc(O)c(O)c1
InChIKey
UCTWMZQNUQWSLP-UHFFFAOYSA-N
Molecular formula
C9H13NO3
Average molar mass
183.2 g/mol
Monoisotopic mass
183.08954328

Overview

3,4-dihydroxyl-alpha-[methylamino]methylbenzyl alcohol appears as odorless light brown or nearly white crystals. (NTP, 1992)

Names & identifiers

Preferred name
(+-)-Adrenaline
IUPAC
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
English name
DL-Adrenalin
Molecular formula
C9H13NO3
Molecular weight
183.2

Names & synonyms

329-65-7Racepinephrine(+-)-AdrenalineEpinephrine, dl-Racemic EpinephrineRacemic adrenalineAdrenaline, racemicEpinephrine, RacemicGR0L9S3J0F4-(1-hydroxy-2-methylaminoethyl)benzene-1,2-diolCHEBI:33568DTXSID80858965
Show more names
(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diolEpinehrineDL-Adrenalisuprarenalinepinaphalene
RefChem:55959DTXCID20196651DL-Adrenalinedl-EpinephrineRacepinefrineEpinephrine racemicDL-AdrenalinEpirenamine

Database identifiers

CAS
329-65-7
PubChem CID
838
DTXSID
DTXSID80858965
ChEMBL
CHEMBL1740
ChEBI
CHEBI:33568
UNII
GR0L9S3J0F
EC Number
206-347-6
Nikkaji
J81.291I

Properties

Computed structural properties

XLogP
-1.4
Topological polar surface area
72.7 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
13
Formal charge
0
Complexity
154

Experimental & physicochemical properties

Solubility · 2 items

Sparingly soluble (NTP, 1992)

Soluble

Melting Point412 to 414 °F (NTP, 1992)
Physical Description3,4-dihydroxyl-alpha-[methylamino]methylbenzyl alcohol appears as odorless light brown or nearly white crystals. (NTP, 1992)

Physicochemical properties

Melting point
197 °C · 197 °C (dec.)(lit.)
Boiling point
316.88 °C · 316.88°C (rough estimate)
alpha
-0.5 · -0.5~+0.5°(D/20)(c=1,0.1mol/l HCl)
Density
1.1967 · 1.1967 (rough estimate)
refractive index
1.476 · 1.4760 (estimate)
storage temp.
2 · 2-8°C
solubility
0.1 M · 0.1 M HCL : 2.5 mg/mL (13.65 mM; ultrasonic and adjust pH to 1 with HCl)DMSO : 1 mg/mL (5.46 mM; ultrasonic and adjust pH to 7 with HCl)Ethanol : < 1 mg/mL (insoluble)H2O : < 0.1 mg/mL (insoluble)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H311 (97.6%): Toxic in contact with skin [Danger Acute toxicity, dermal]

P261, P262, P264, P264+P265, P270, P271, P280, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

DOT LabelPoison
Fire HazardsFlash point data for this compound are not available, however, it is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Pallor, tremor, anxiety, nervousness, rapid, forceful pulse, rise in blood pressure and temperature, rapid breathing, dilation of the pupils. (NTP, 1992)
Reactive GroupAmines, Phosphines, and Pyridines
Reactivity Profile · 1 item

Light sensitive. Incompatible with heat, air, iron salts, and alkalis. (NTP, 1992). An organic compound with both amine and alcohol substituents. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides. Incompatible with heat, air, iron salts, and alkalis. (NTP, 1992).

Chemistry & industry

Pharmacology

Protein BindingTo refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].
Pharmacodynamics · 1 item

Epinephrine acts on α- and β-adrenergic receptors. When given subcutaneously or intramuscularly, epinephrine has a rapid onset and short duration of action. Epinephrine induces bronchial smooth muscle relaxation to relieve respiratory distress in asthma. In a clinical trial of paediatric patients with bronchiolitis, administration of aerosolized racemic epinephrine via inhalation resulted in improved clinical symptoms such as wheezing and retractions. The clinical efficacy of racemic epinephrine was comparable to that of salbutamol or albuterol, which are commonly used bronchodilators.

Mechanism of Action · 1 item

Epinephrine is a non-selective agonist at α- and β-adrenergic receptors, which are all G-protein-coupled receptors. The main therapeutic effect of epinephrine arises from its agonist action on β2-adrenergic receptors, which activate adenylyl cyclase and increase intracellular cyclic AMP production. Epinephrine causes smooth muscle relaxation on various tissues, including bronchial smooth muscles. As a result, epinephrine serves to alleviate bronchospasm, wheezing and tightness of chest that may occur during asthmatic attacks. Via its relaxer effects on the smooth muscle of the stomach, intestine, uterus and urinary bladder, epinephrine may also alleviate pruritus, urticaria, and angioedema and may relieve gastrointestinal and genitourinary symptoms associated with anaphylaxis. Epinephrine also acts on the α-adrenergic receptors on vascular smooth muscles, particularly in the skin and splanchnic vascular beds, to cause constriction. Epinephrine is thought to reduce capillary leakage by constricting precapillary arterioles, reducing hydrostatic pressure and consequently bronchial mucosal edema.

Biological Half-LifeTo refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].
Metabolism/MetabolitesTo refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].

Related reactions

2 records
New reaction record
HRID 324713 reaction equation
HRID 324713As product
HRID 1762768 reaction equation
HRID 1762768As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
pka
9.6 · 9.60±0.10(Predicted)
form
Powder
Water Solubility
Sparingly soluble
Sensitive
Light Sensitive
Merck
14 · 14,3619
InChI
InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3
InChIKey
UCTWMZQNUQWSLP-UHFFFAOYSA-N
SMILES
C1(O)=CC=C(C(O)CNC)C=C1O
CAS DataBase Reference
329 · 329-65-7(CAS DataBase Reference)
FDA UNII
0 L9S3J0F · GR0L9S3J0F
EPA Substance Registry System
4 · 4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (329-65-7)
Symbol(GHS)
6 · GHS06
Signal word
Warning
Hazard statements
311 · H311-H315-H319-H335
Precautionary statements
261 · P261-P280-P304+P340-P305+P351+P338-P405-P501a
Hazard Codes
T
Risk Statements
24 · 24-36/37/38
Safety Statements
26 · 26-36/37-45
RIDADR
2811 · UN 2811 6.1/PG 2
WGK Germany
3 · 3
RTECS
2975000 · DO2975000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
Air and Water Reactions
Slightly water soluble (NTP, 1992).
Hazard Classes and CategoriesAcute Tox. 3 (97.6%)

Safety & protection

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide, foam, or Halon extiguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with 5% acetic acid, then transfer the dampened material to a suitable container. Use absorbent paper dampened with 5% acetic acid to pick up any remaining material. Your contaminated clothing and the absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with 5% acetic acid followed by washing with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

Safety data

wgk
3
rtecs
DO2975000
ridadr
UN 2811 6.1/PG 2
risk_code
24-36/37/38
Signal word
Warning
Symbol(GHS)
GHS06
hazard_code
T
safety_code
26-36/37-45
hazard_class
6.1(b)
packing_group
III
Hazard statements
H311-H315-H319-H335
Precautionary statements
P261-P280-P304+P340-P305+P351+P338-P405-P501a
MeSH Pharmacological Classification · 6 items

Drugs that selectively bind to and activate alpha adrenergic receptors.

Drugs that selectively bind to and activate beta-adrenergic receptors.

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Drugs used to cause constriction of the blood vessels.

Absorption, Distribution and Excretion · 4 items

To refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].

To refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].

To refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].

To refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].

Applications · 4 items

UsesEndogenous catcholamine with combined α-and β-agonist activity. Principal sympathomimetic hormone produced by the adrenal medulla. Bronchodilator; cardiostimulant; mydriatic; antiglaucoma.

UsesDL-Adrenaline is a hormone and a neurotransmitter secreted by the medulla of the adrenal glands. In medicine DL-Adrenaline is used chiefly as a stimulant in cardiac arrest, as a vasoconstrictor in shock, and as a bronchodilator and antispasmodic in bronch

UsesA hormone and neurotransmitter

General DescriptionOdorless light brown or nearly white crystals.

Upstream & downstream products

Downstream products

L(-)-Epinephrine

Additional notes

DefinitionChEBI: A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen.